Global Age-Related Macular Degeneration (AMD) Market 2014-2018


◆タイトル:Global Age-Related Macular Degeneration (AMD) Market 2014-2018
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:pdf / 英語
Single UserUSD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥305,200見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥381,500見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。



About AMD
AMD is defined as the deterioration of the eye’s macula. The macula is a small area in the retina that is responsible for central vision. The exact etiology of AMD is unknown. There are two types of macular degeneration: wet and dry. Wet AMD occurs when tiny abnormal blood vessels begin growing behind the retina toward the macula. Dry AMD occurs when small, yellowish deposits called drusen begin accumulating beneath the macula. While a number of treatments are available for wet AMD, there is no treatment available at the moment for dry AMD.
TechNavio’s analysts forecast the Global AMD market will grow at a CAGR of 6.62 percent over the period 2013-2018.
Covered in this Report
The Global AMD market can be divided into two segments: Dry AMD and Wet AMD. This report covers the present scenario and the growth prospects of the Global AMD market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of AMD.
TechNavio’s report, the Global AMD Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global AMD market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
Key Vendors
• Bayer AG
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Regeneron Pharmaceuticals Inc.
Other Prominent Vendors

• Acucela Inc.
• Advanced Cell Technology Inc.
• Alexion Pharmaceuticals Inc.
• Alimera Sciences Inc.
• Allergen Inc.
• Allergo Opthalmics LLC
• Avalanche Biotechnologies Inc.
• Gilead Sciences Inc.
• GlaxoSmithKline plc
• Icon Bioscience Inc.
• Intellect Neurosciences Inc.
• Lpath Inc.
• Neurotech Pharmaceuticals Inc.
• Opthotech Corp.
• OSI Pharmaceuticals Inc.
• Oxigene Inc.
• PanOptica Inc.
• Pfizer Inc.
• Santen Pharmaceutical Co. Ltd.
• StemCells Inc.
• Synthetic Biologics Inc.
• Thrombogenics NV
• Valeant Pharmaceuticals International Inc.
Key Market Driver
• Increase in Aging Population.
• For a full, detailed list, view our report.
Key Market Challenge
• Increase in Off Label Use.
• For a full, detailed list, view our report.
Key Market Trend
• Increase in Awareness of AMD.
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
03.2.1 Product Profiles
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Product Portfolio of Current AMD Therapies
08. Clinical Pipeline Portfolio
09. Rate of Incidence and Prevalence
09.1.1 US
09.1.2 UK
09.1.3 Australia
09.1.4 Japan
09.1.5 China
09.1.6 India
10. Market Segmentation by Types
11. Geographical Segmentation
11.1 AMD Market in the Americas
11.1.1 Market Size and Forecast
11.2 AMD Market in the EMEA Region
11.2.1 Market Size and Forecast
11.3 AMD Market in the APAC Region
11.3.1 Market Size and Forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Analysis 2013
19.3 Other Prominent Vendors
19.4 Future Vendors Expected To Tap AMD Market
20. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global AMD Market 2013-2018 (US$ billion)
Exhibit 3: Global AMD Market Segmentation by Types
Exhibit 4: Global AMD Market by Geographical Segmentation 2013
Exhibit 5: AMD Market in the Americas 2013-2018 (US$ billion)
Exhibit 6: AMD Market in the EMEA Region 2013-2018 (US$ billion)
Exhibit 7: Global AMD Market by Major Product Share 2013


Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Acucela Inc., Advanced Cell Technology Inc., Alexion Pharmaceuticals Inc., Alimera Sciences Inc., Allergen Inc., Allergo Opthalmics LLC, Avalanche Biotechnologies Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Icon Bioscience Inc., Intellect Neurosciences Inc., Lpath Inc., Neurotech Pharmaceuticals Inc., Opthotech Corp., OSI Pharmaceuticals Inc., Oxigene Inc.
, PanOptica Inc., Pfizer Inc., Santen Pharmaceutical Co. Ltd., StemCells Inc., Synthetic Biologics Inc., Thrombogenics NV, Valeant Pharmaceuticals International Inc.





★調査レポート[グローバルにおける加齢黄斑変性(AMD)治療市場(2014-2018)] (Global Age-Related Macular Degeneration (AMD) Market 2014-2018 / IRTNTR3530)販売に関する免責事項
[グローバルにおける加齢黄斑変性(AMD)治療市場(2014-2018)] (Global Age-Related Macular Degeneration (AMD) Market 2014-2018 / IRTNTR3530)についてEメールでお問い合わせ